Symbio Pharmaceuticals

Japan - Tokyo

Pharmaceutical3 H-1B visas (FY2023)

Focus: Small Molecules

Symbio Pharmaceuticals is a life sciences company focused on Small Molecules.

OncologyNeurology

Open Jobs

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

H-1B (2023): 3 approvals

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub